Concepts (123)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Disease, Chronic Obstructive | 6 | 2024 | 143 | 1.240 |
Why?
|
| Sarcoidosis | 4 | 2020 | 11 | 0.930 |
Why?
|
| Hospitals, Teaching | 1 | 2021 | 24 | 0.820 |
Why?
|
| Seasons | 1 | 2021 | 112 | 0.790 |
Why?
|
| Comorbidity | 2 | 2017 | 606 | 0.770 |
Why?
|
| Hospital Mortality | 1 | 2021 | 183 | 0.730 |
Why?
|
| Teaching Rounds | 1 | 2019 | 4 | 0.700 |
Why?
|
| Diagnostic Techniques, Respiratory System | 1 | 2017 | 2 | 0.630 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2017 | 11 | 0.630 |
Why?
|
| Referral and Consultation | 1 | 2017 | 110 | 0.590 |
Why?
|
| Medicaid | 1 | 2017 | 102 | 0.560 |
Why?
|
| Telemedicine | 1 | 2019 | 163 | 0.540 |
Why?
|
| Lung | 2 | 2012 | 413 | 0.330 |
Why?
|
| Socioeconomic Factors | 2 | 2007 | 1003 | 0.280 |
Why?
|
| United States | 4 | 2021 | 3894 | 0.250 |
Why?
|
| Middle Aged | 9 | 2023 | 9642 | 0.250 |
Why?
|
| Airway Obstruction | 1 | 2024 | 9 | 0.240 |
Why?
|
| Humans | 18 | 2024 | 34853 | 0.240 |
Why?
|
| Retrospective Studies | 4 | 2021 | 1961 | 0.230 |
Why?
|
| Hospitalization | 1 | 2006 | 370 | 0.230 |
Why?
|
| Intensive Care Units | 2 | 2021 | 57 | 0.220 |
Why?
|
| Respiratory Insufficiency | 1 | 2021 | 13 | 0.200 |
Why?
|
| Vaccines | 1 | 2021 | 49 | 0.200 |
Why?
|
| Radiography, Thoracic | 1 | 2000 | 9 | 0.190 |
Why?
|
| Sarcoidosis, Pulmonary | 1 | 2020 | 2 | 0.190 |
Why?
|
| Adult | 6 | 2021 | 11034 | 0.190 |
Why?
|
| Length of Stay | 1 | 2021 | 184 | 0.190 |
Why?
|
| Liver Diseases | 1 | 2020 | 31 | 0.180 |
Why?
|
| Postoperative Complications | 1 | 2021 | 206 | 0.180 |
Why?
|
| Internship and Residency | 1 | 2021 | 121 | 0.180 |
Why?
|
| Depressive Disorder, Major | 1 | 2021 | 102 | 0.180 |
Why?
|
| Male | 10 | 2021 | 18870 | 0.180 |
Why?
|
| Cardiomyopathies | 1 | 2020 | 55 | 0.180 |
Why?
|
| Erythrocyte Transfusion | 1 | 2018 | 18 | 0.160 |
Why?
|
| Kidney Diseases | 1 | 2020 | 159 | 0.160 |
Why?
|
| Reproducibility of Results | 2 | 2017 | 901 | 0.160 |
Why?
|
| Smoking | 3 | 2023 | 903 | 0.160 |
Why?
|
| Female | 8 | 2021 | 19873 | 0.160 |
Why?
|
| Cohort Studies | 2 | 2023 | 1422 | 0.160 |
Why?
|
| Hospitals, University | 1 | 2017 | 38 | 0.160 |
Why?
|
| International Cooperation | 1 | 2017 | 44 | 0.160 |
Why?
|
| Malaria, Falciparum | 1 | 2018 | 81 | 0.150 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 211 | 0.150 |
Why?
|
| Clinical Competence | 1 | 2017 | 124 | 0.150 |
Why?
|
| Quality of Health Care | 1 | 2017 | 136 | 0.140 |
Why?
|
| Anemia, Sickle Cell | 1 | 2018 | 169 | 0.140 |
Why?
|
| Prognosis | 1 | 2017 | 707 | 0.130 |
Why?
|
| Spirometry | 2 | 2024 | 33 | 0.120 |
Why?
|
| Adolescent | 3 | 2021 | 5035 | 0.120 |
Why?
|
| Forced Expiratory Volume | 2 | 2024 | 68 | 0.120 |
Why?
|
| Cross-Sectional Studies | 3 | 2024 | 2561 | 0.110 |
Why?
|
| Emphysema | 1 | 2012 | 5 | 0.110 |
Why?
|
| Incidence | 2 | 2021 | 882 | 0.100 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2012 | 206 | 0.100 |
Why?
|
| Poliovirus | 1 | 1988 | 5 | 0.080 |
Why?
|
| Picornaviridae | 1 | 1988 | 4 | 0.080 |
Why?
|
| Genes | 1 | 1988 | 58 | 0.080 |
Why?
|
| Peptide Hydrolases | 1 | 1988 | 33 | 0.080 |
Why?
|
| Genes, Viral | 1 | 1988 | 62 | 0.080 |
Why?
|
| Protein Biosynthesis | 1 | 1988 | 123 | 0.080 |
Why?
|
| Radiography | 1 | 2007 | 75 | 0.080 |
Why?
|
| Quality of Life | 1 | 2011 | 459 | 0.080 |
Why?
|
| Observer Variation | 2 | 2012 | 57 | 0.070 |
Why?
|
| Young Adult | 1 | 2017 | 4012 | 0.070 |
Why?
|
| Chronic Disease | 2 | 2007 | 469 | 0.070 |
Why?
|
| Protein Processing, Post-Translational | 1 | 1988 | 162 | 0.070 |
Why?
|
| Polycythemia | 1 | 2006 | 15 | 0.070 |
Why?
|
| Viral Proteins | 1 | 1988 | 172 | 0.070 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2006 | 11 | 0.070 |
Why?
|
| Scleroderma, Systemic | 1 | 2006 | 17 | 0.070 |
Why?
|
| Age Distribution | 1 | 2006 | 223 | 0.070 |
Why?
|
| Sex Distribution | 1 | 2006 | 212 | 0.070 |
Why?
|
| Severity of Illness Index | 1 | 2007 | 608 | 0.060 |
Why?
|
| Disease Progression | 1 | 2007 | 580 | 0.060 |
Why?
|
| Dyspnea | 1 | 2024 | 15 | 0.060 |
Why?
|
| Phenotype | 1 | 2006 | 650 | 0.060 |
Why?
|
| Vital Capacity | 1 | 2023 | 38 | 0.060 |
Why?
|
| Risk Factors | 2 | 2011 | 3414 | 0.060 |
Why?
|
| Case-Control Studies | 2 | 2019 | 1056 | 0.060 |
Why?
|
| Nutrition Surveys | 1 | 2024 | 228 | 0.050 |
Why?
|
| Respiration, Artificial | 1 | 2021 | 37 | 0.050 |
Why?
|
| Critical Illness | 1 | 2021 | 37 | 0.050 |
Why?
|
| Pulmonary Medicine | 1 | 2020 | 1 | 0.050 |
Why?
|
| Endosonography | 1 | 2020 | 3 | 0.050 |
Why?
|
| Mediastinum | 1 | 2020 | 5 | 0.050 |
Why?
|
| Bronchoscopy | 1 | 2020 | 6 | 0.050 |
Why?
|
| Aspartate Aminotransferases | 1 | 2020 | 15 | 0.050 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2020 | 11 | 0.050 |
Why?
|
| Alanine Transaminase | 1 | 2020 | 26 | 0.050 |
Why?
|
| Hypercalcemia | 1 | 2020 | 12 | 0.050 |
Why?
|
| Alkaline Phosphatase | 1 | 2020 | 48 | 0.050 |
Why?
|
| Eye Diseases | 1 | 2020 | 23 | 0.050 |
Why?
|
| Longitudinal Studies | 1 | 2023 | 841 | 0.050 |
Why?
|
| Societies, Medical | 1 | 2020 | 62 | 0.050 |
Why?
|
| Creatinine | 1 | 2020 | 101 | 0.050 |
Why?
|
| Lymph Nodes | 1 | 2020 | 67 | 0.050 |
Why?
|
| Positron-Emission Tomography | 1 | 2020 | 79 | 0.050 |
Why?
|
| Vaccination | 1 | 2021 | 259 | 0.050 |
Why?
|
| Biopsy | 1 | 2020 | 151 | 0.040 |
Why?
|
| Electrocardiography | 1 | 2020 | 154 | 0.040 |
Why?
|
| Echocardiography | 1 | 2020 | 144 | 0.040 |
Why?
|
| Hypertension, Pulmonary | 1 | 2020 | 77 | 0.040 |
Why?
|
| Aged | 3 | 2019 | 6448 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2021 | 964 | 0.040 |
Why?
|
| Multiple Organ Failure | 1 | 2018 | 6 | 0.040 |
Why?
|
| Vitamin D | 1 | 2020 | 176 | 0.040 |
Why?
|
| Antimalarials | 1 | 2018 | 48 | 0.040 |
Why?
|
| Calcium | 1 | 2020 | 445 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2020 | 468 | 0.040 |
Why?
|
| Depression | 1 | 2021 | 664 | 0.030 |
Why?
|
| Education | 1 | 2012 | 48 | 0.030 |
Why?
|
| Linear Models | 1 | 2011 | 253 | 0.020 |
Why?
|
| Research Design | 1 | 2012 | 292 | 0.020 |
Why?
|
| Age Factors | 1 | 2011 | 1007 | 0.020 |
Why?
|
| Molecular Weight | 1 | 1988 | 161 | 0.020 |
Why?
|
| Prevalence | 1 | 2012 | 1425 | 0.020 |
Why?
|
| DNA Replication | 1 | 1988 | 148 | 0.020 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2006 | 13 | 0.020 |
Why?
|
| Headache | 1 | 2006 | 18 | 0.020 |
Why?
|
| Vision, Low | 1 | 2006 | 13 | 0.020 |
Why?
|
| Erythropoietin | 1 | 2006 | 37 | 0.020 |
Why?
|
| Virus Replication | 1 | 1988 | 261 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2011 | 2333 | 0.020 |
Why?
|